These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30886755)

  • 21. Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics.
    Whaley NR; Fujioka S; Wszolek ZK
    Orphanet J Rare Dis; 2011 May; 6():33. PubMed ID: 21619691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treadmill training increases the motor activity and neuron survival of the cerebellum in a mouse model of spinocerebellar ataxia type 1.
    Chuang CS; Chang JC; Soong BW; Chuang SF; Lin TT; Cheng WL; Orr HT; Liu CS
    Kaohsiung J Med Sci; 2019 Nov; 35(11):679-685. PubMed ID: 31271500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of d-cysteine against in vitro and in vivo models of spinocerebellar ataxia.
    Ohta T; Morikawa Y; Sato M; Konno A; Hirai H; Kurauchi Y; Hisatsune A; Katsuki H; Seki T
    Exp Neurol; 2021 Sep; 343():113791. PubMed ID: 34157318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCA 1, SCA 2 & SCA 3/MJD mutations in ataxia syndromes in southern India.
    Krishna N; Mohan S; Yashavantha BS; Rammurthy A; Kiran Kumar HB; Mittal U; Tyagi S; Mukerji M; Jain S; Pal PK; Purushottam M
    Indian J Med Res; 2007 Nov; 126(5):465-70. PubMed ID: 18160752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-motor symptoms in patients with autosomal dominant spinocerebellar ataxia.
    Mastammanavar VS; Kamble N; Yadav R; M N; Jain S; Kumar K; Pal PK
    Acta Neurol Scand; 2020 Oct; 142(4):368-376. PubMed ID: 32677041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A familial case of spinocerebellar ataxia type 8 (SCA 8)--its clinical findings and an issue about the genetic basis].
    Hokezu Y; Takiyama Y; Sakoe K; Nagamatsu K
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1116-21. PubMed ID: 11332193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of extrapyramidal manifestations in 85 patients with spinocerebellar ataxia type 1, 2 and 3.
    Jhunjhunwala K; Netravathi M; Purushottam M; Jain S; Pal PK
    J Clin Neurosci; 2014 Jun; 21(6):1002-6. PubMed ID: 24602359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presenile onset of spinocerebellar ataxia type 1 presenting with conspicuous psychiatric symptoms and widespread anti-expanded polyglutamine antibody- and fused in sarcoma antibody-immunopositive pathology.
    Iwasaki Y; Mori K; Ito M; Mimuro M; Yoshida M
    Psychogeriatrics; 2015 Sep; 15(3):212-7. PubMed ID: 25920043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic Differences in Networks Supporting Regional Predictors of Speech Rate in Spinocerebellar Ataxia: Preliminary Observations.
    Sidtis JJ; Gomez CM
    Brain Connect; 2021 Aug; 11(6):408-417. PubMed ID: 34030481
    [No Abstract]   [Full Text] [Related]  

  • 33. Hippocampal mitochondrial dysfunction and psychiatric-relevant behavioral deficits in spinocerebellar ataxia 1 mouse model.
    Tichanek F; Salomova M; Jedlicka J; Kuncova J; Pitule P; Macanova T; Petrankova Z; Tuma Z; Cendelin J
    Sci Rep; 2020 Mar; 10(1):5418. PubMed ID: 32214165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
    Oda M; Maruyama H; Komure O; Morino H; Terasawa H; Izumi Y; Imamura T; Yasuda M; Ichikawa K; Ogawa M; Matsumoto M; Kawakami H
    Arch Neurol; 2004 Feb; 61(2):209-12. PubMed ID: 14967767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
    Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
    Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in sleep stage R scoring in patients with autosomal dominant spinocerebellar ataxias (SCA1, SCA2 and SCA3) and oculomotor abnormalities: a whole night polysomnographic evaluation.
    Seshagiri DV; Sasidharan A; Kumar G; Pal PK; Jain S; Kutty BM; Yadav R
    Sleep Med; 2018 Feb; 42():97-102. PubMed ID: 29458753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression and clinical progression in spinocerebellar ataxias.
    Lo RY; Figueroa KP; Pulst SM; Perlman S; Wilmot G; Gomez C; Schmahmann J; Paulson H; Shakkottai VG; Ying S; Zesiewicz T; Bushara K; Geschwind M; Xia G; Yu JT; Lee LE; Ashizawa T; Subramony SH; Kuo SH
    Parkinsonism Relat Disord; 2016 Jan; 22():87-92. PubMed ID: 26644294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CAG trinucleotide mutation detection in patients with hereditary spinocerebellar ataxia].
    Tang B; Xia J; Wang D; Tang X; Shen L; Liu C; Dai H; Yan X; Pan Q; Xiao J; Zhang B; Ou Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Oct; 16(5):281-4. PubMed ID: 10514531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3.
    Klockgether T; Skalej M; Wedekind D; Luft AR; Welte D; Schulz JB; Abele M; Bürk K; Laccone F; Brice A; Dichgans J
    Brain; 1998 Sep; 121 ( Pt 9)():1687-93. PubMed ID: 9762957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.